Back to search

Ireland· IE-PA-EU/1/09/600/001

Zutectra 500 IU solution for injection in pre-filled syringe

A hepatitis b immunoglobulin product containing human plasma protein >96% immunoglobulins + hbs antibodies, registered in Ireland by Biotest Pharma GmbH. The same ATC class is registered in 12 of our 19 countries.

ATC J06BB04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedZutectra 500 IU solution for injectio…ATCJ06BB04REGISTER NO.IE-PA-EU/1/09/600/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Hepatitis b immunoglobulin is registered in 12 of 19 countries.

Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Hepatitis b immunoglobulin · ATC J06BB04

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Human plasma protein >96% immunoglobulins + Hbs antibodies
Manufacturer
Biotest Pharma GmbH
Country
Ireland (IE)
ATC code
J06BB04
ATC class
Hepatitis B immunoglobulin
Defined daily dose
500 E, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/09/600/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e73df200-c0c7-48c2-8beb-a0998746c39d
GET /v1/drugs/e73df200-c0c7-48c2-8beb-a0998746c39d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J06BB",
    "J06BB04"
  ],
  "strength": null,
  "pa_number": "EU/1/09/600/001",
  "substances": [
    "Human plasma protein >96% immunoglobulins",
    "Hbs antibodies"
  ],
  "legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "30/11/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about hepatitis b immunoglobulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.